Escient Pharmaceuticals, Inc   Report issue

For profit Phase 2
Founded: San Diego CA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04510090
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Escient Pharmaceuticals, Inc

Active Ingredients

Drugs in Phase 2 Trials (2)

ep262 (3 trials)

ep547 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholestasis (Phase 1)

Pruritus (Phase 1)

Renal Insufficiency (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2